Biotech

All Articles

Galecto buys leukemia medicine, goes down bone cancer asset in pivot

.A year after the breakdown of an idiopathic lung fibrosis applicant delivered Galecto on a look for...

Judo throws down $100M to knock out renal condition

.Taking the mat is actually Judo Bio, an up-and-coming biotech armed along with $one hundred million...

AstraZeneca pays CSPC $100M for preclinical heart disease drug

.AstraZeneca has actually settled CSPC Drug Team $one hundred thousand for a preclinical cardiovascu...

Zephyrm finds Hong Kong IPO to fund period 3 cell therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, submission (PDF) for an IPO to ...

Frazier Lifestyle Sciences collects $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has actually sourced a further $630 thousand for its fund concentrated ...

GigaGen gets up to $135M BARDA dollars to hammer botox

.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its own...

GPCR agency Septerna files for IPO on stamina of preclinical records

.Septerna is about to find out exactly how a biotech without "any significant professional informati...

Kurma shuts initially $154M payload for largest biotech fund as yet

.International VC firm Kurma Partners has introduced its own most current biotech fund, along with 1...

Prothena advertises one director while one more leaves behind-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...

Editas capitalize Vertex Cas9 licensing liberties for $57M

.Against the scenery of a Cas9 license war that declines to die, Editas Medicine is cashing in a par...